EntryPoint Capital’s MaxLinear MXL Stock Holding History

EntryPoint Capital’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,637	Closed	-$151K	–	802
2025 Q2	$151K	Buy	+10,637	New	+$123K	0.08%	533
2024 Q3	–	Sell	-7,795	Closed	-$157K	–	1096
2024 Q2	$157K	Buy	7,795 +4,616	+145%	+$90.7K	0.07%	538
2024 Q1	$59.4K	Buy	+3,179	New	+$63.5K	0.05%	674

Other funds holding MXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

EntryPoint Capital's MXL Position: Q3 2025 in Review

EntryPoint Capital sold out of MaxLinear (MXL) in Q3 2025, closing a stake of 10,637 shares — an estimated $151K sold.

EntryPoint Capital first reported a position in MXL in Q1 2024 and held it in 3 quarters. The position peaked at $157K in Q2 2024. 239 funds tracked by Wall St. Rank hold MXL as of Q3 2025.

EntryPoint Capital reported no remaining MaxLinear position as of Q3 2025 after selling out during the quarter.
EntryPoint Capital sold 10,637 MaxLinear shares in Q3 2025, an estimated $151K.
EntryPoint Capital first reported a position in MaxLinear in Q1 2024 and held it in 3 quarters.
EntryPoint Capital's MaxLinear position peaked at $157K in Q2 2024.
239 funds tracked by Wall St. Rank held MaxLinear as of Q3 2025.

Based on EntryPoint Capital's 13F filing for Q3 2025, filed 13 Nov 2025.